Repligen financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

레플리젠NASDAQ:RGEN · Nasdaq · Healthcare

$181.70+2.52%

2026-10-02 close

Repligen's published financial data is dated 2026-10-04. 2024 revenue was $634M. 2024 operating profit was −$35M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy